StepStone leads $670m multi-fund healthcare restructuring
Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.
26 November 2020•2 mins read
Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.
